Insight Pharma Reports Announces: Autoimmune Diseases Report

July 13, 2011 - PRLog -- NEEDHAM, MASS.  Cambridge Healthtech Institute’s Insight Pharma Reports announces the Autoimmune Diseases - Pipelines for Crohn’s Disease, Multiple Sclerosis and Rheumatoid Arthritis Report, Authored by Lucy Sannes, PhD, MBA.

This report focuses on current and pipeline candidate therapeutics and their respective targets for three autoimmune diseases and answers such questions as:

•   Who are the companies with active development programs for these diseases?
•   Which targets are actively being investigated and what new targets are coming forward?
•   Who has candidates in active Phase III and Phase II clinical trials?
•   What does the overall target activity map, from launched drug to preclinical research candidates look like?
•   Where are next generation biological therapeutics found across these three diseases?
•   Are small molecules a significant portion of the development activity?

Autoimmune Diseases: Pipelines for Crohn’s Disease, Multiple Sclerosis and Rheumatoid Arthritis describes pipeline activities across these three diseases. We report on the:


•   Development pipelines for each disease providing information on company and licensee involvement.
•   Active Phase III and Phase II clinical trials and provide study completion dates.
•   Targets involved across the spectrum of launched and preclinical activities.
•   Competition among companies developing therapeutics targeting the same or related physiology.
•   Pace of development activities across these three diseases.
•   Small or specialty companies with innovative therapy development programs.

For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com

About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://insightpharmareports.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.